Inhibrx Biosciences, Inc. has grown revenue −15% a year over three years and −15% a year over five. Revenue growth, 3-year annual rate: −15% (Biotechnology median +21%). Revenue growth, 5-year rate: −15%, growth has slowed since the five-year average. Years of annual history on file: 3, FY2023 to FY2025, as filed.

INBXInhibrx Biosciences, Inc.

HealthcareUSD

$125.28

$21.0652 weeks$141.84

Is it growing?

Is INBX growing?

Inhibrx Biosciences, Inc. has grown revenue −15% a year over three years and −15% a year over five.

−15%

Revenue growth, 3-year annual rate · Biotechnology median +21% · shrinking · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: −15%
Revenue growth, 5-year rate · −15% over three · growth has slowed since the five-year average
Years of annual history on file: 3
Years of annual history on file · FY2023 to FY2025, as filed

Details›